161 related articles for article (PubMed ID: 32203558)
1. N-acetylcysteine (NAC), an anti-oxidant, does not improve bone mechanical properties in a rat model of progressive chronic kidney disease-mineral bone disorder.
Allen MR; Wallace J; McNerney E; Nyman J; Avin K; Chen N; Moe S
PLoS One; 2020; 15(3):e0230379. PubMed ID: 32203558
[TBL] [Abstract][Full Text] [Related]
2. Effect of ovariectomy on the progression of chronic kidney disease-mineral bone disorder (CKD-MBD) in female Cy/+ rats.
Vorland CJ; Lachcik PJ; Swallow EA; Metzger CE; Allen MR; Chen NX; Moe SM; Hill Gallant KM
Sci Rep; 2019 May; 9(1):7936. PubMed ID: 31138895
[TBL] [Abstract][Full Text] [Related]
3. Adverse Effects of Autoclaved Diets on the Progression of Chronic Kidney Disease and Chronic Kidney Disease-Mineral Bone Disorder in Rats.
Biruete A; Srinivasan S; O'Neill KD; Vorland CJ; Hill Gallant KM; Cai W; Uribarri J; Johnston N; Allen MR; Chen NX; Moe SM
Am J Nephrol; 2020; 51(5):381-389. PubMed ID: 32146472
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid suppression therapy normalizes chronic kidney disease-induced elevations in cortical bone vascular perfusion: a pilot study.
Aref MW; Swallow EA; Metzger CE; Chen N; Moe SM; Allen MR
Osteoporos Int; 2019 Aug; 30(8):1693-1698. PubMed ID: 31069439
[TBL] [Abstract][Full Text] [Related]
5. Effects of ferric citrate and intravenous iron sucrose on markers of mineral, bone, and iron homeostasis in a rat model of CKD-MBD.
Biruete A; Metzger CE; Chen NX; Swallow EA; Vrabec C; Clinkenbeard EL; Stacy AJ; Srinivasan S; O'Neill K; Avin KG; Allen MR; Moe SM
Nephrol Dial Transplant; 2022 Sep; 37(10):1857-1867. PubMed ID: 35482713
[TBL] [Abstract][Full Text] [Related]
6. N-acetylcysteine prevents endoplasmic reticulum stress elicited in macrophages by serum albumin drawn from chronic kidney disease rats and selectively affects lipid transporters, ABCA-1 and ABCG-1.
Machado JT; Iborra RT; Fusco FB; Castilho G; Pinto RS; Machado-Lima A; Nakandakare ER; Seguro AC; Shimizu MH; Catanozi S; Passarelli M
Atherosclerosis; 2014 Nov; 237(1):343-52. PubMed ID: 25305669
[TBL] [Abstract][Full Text] [Related]
7. Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy.
Moe SM; Chen NX; Newman CL; Organ JM; Kneissel M; Kramer I; Gattone VH; Allen MR
J Bone Miner Res; 2015 Mar; 30(3):499-509. PubMed ID: 25407607
[TBL] [Abstract][Full Text] [Related]
8. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
Meng Y; Zhang H; Li Y; Li Q; Zuo L
Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
[TBL] [Abstract][Full Text] [Related]
9. Compromised vertebral structural and mechanical properties associated with progressive kidney disease and the effects of traditional pharmacological interventions.
Newman CL; Chen NX; Smith E; Smith M; Brown D; Moe SM; Allen MR
Bone; 2015 Aug; 77():50-6. PubMed ID: 25892482
[TBL] [Abstract][Full Text] [Related]
10. The intervention effect of zuogui pill on chronic kidney disease-mineral and bone disorder regulatory factor.
Ma X; He L
Biomed Pharmacother; 2018 Oct; 106():54-60. PubMed ID: 29957466
[TBL] [Abstract][Full Text] [Related]
11. Calcimimetics Alter Periosteal and Perilacunar Bone Matrix Composition and Material Properties in Early Chronic Kidney Disease.
Damrath JG; Moe SM; Wallace JM
J Bone Miner Res; 2022 Jul; 37(7):1297-1306. PubMed ID: 35593150
[TBL] [Abstract][Full Text] [Related]
12. Cortical porosity development and progression is mitigated after etelcalcetide treatment in an animal model of chronic kidney disease.
Swallow EA; Metzger CE; Newman CL; Chen NX; Moe SM; Allen MR
Bone; 2022 Apr; 157():116340. PubMed ID: 35085840
[TBL] [Abstract][Full Text] [Related]
13. Effect of Advanced Glycation End-Products (AGE) Lowering Drug ALT-711 on Biochemical, Vascular, and Bone Parameters in a Rat Model of CKD-MBD.
Chen NX; Srinivasan S; O'Neill K; Nickolas TL; Wallace JM; Allen MR; Metzger CE; Creecy A; Avin KG; Moe SM
J Bone Miner Res; 2020 Mar; 35(3):608-617. PubMed ID: 31743501
[TBL] [Abstract][Full Text] [Related]
14. Intravenous glutathione prevents renal oxidative stress after coronary angiography more effectively than oral N-acetylcysteine.
Saitoh T; Satoh H; Nobuhara M; Machii M; Tanaka T; Ohtani H; Saotome M; Urushida T; Katoh H; Hayashi H
Heart Vessels; 2011 Sep; 26(5):465-72. PubMed ID: 21127883
[TBL] [Abstract][Full Text] [Related]
15. Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease.
Newman CL; Creecy A; Granke M; Nyman JS; Tian N; Hammond MA; Wallace JM; Brown DM; Chen N; Moe SM; Allen MR
Kidney Int; 2016 Jan; 89(1):95-104. PubMed ID: 26489025
[TBL] [Abstract][Full Text] [Related]
16. Salutary effects of N-acetylcysteine on apoptotic damage in a rat model of testicular torsion.
Payabvash S; Salmasi AH; Kiumehr S; Tavangar SM; Nourbakhsh B; Faghihi SH; Dehpour AR
Urol Int; 2007; 79(3):248-54. PubMed ID: 17940358
[TBL] [Abstract][Full Text] [Related]
17. Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).
Ruospo M; Palmer SC; Natale P; Craig JC; Vecchio M; Elder GJ; Strippoli GF
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006023. PubMed ID: 30132304
[TBL] [Abstract][Full Text] [Related]
18. Combining raloxifene and mechanical loading improves bone composition and mechanical properties in a murine model of chronic kidney disease (CKD).
Surowiec RK; Reul ON; Chowdhury NN; Rai RK; Segvich D; Tomaschke AA; Damrath J; Jacobson AM; Allen MR; Wallace JM
Bone; 2024 Jun; 183():117089. PubMed ID: 38575047
[TBL] [Abstract][Full Text] [Related]
19. Effects of triangle grass decoction on bone metabolism in rats with chronic kidney disease complicated with mineral and bone abnormalities.
Liu L; Wang L; Li L; Wang H; Yuan L; Kang L; Jiang Q; Chen G; Lv N; Cui X; Huang L; Wu H; Xu J; Li Y
J Ethnopharmacol; 2021 Jul; 275():114126. PubMed ID: 33872749
[TBL] [Abstract][Full Text] [Related]
20. N-acetylcysteine on oxidative damage in diabetic rats.
Ribeiro G; Roehrs M; Bairros A; Moro A; Charão M; Araújo F; Valentini J; Arbo M; Brucker N; Moresco R; Leal M; Morsch V; Garcia SC
Drug Chem Toxicol; 2011 Oct; 34(4):467-74. PubMed ID: 21770721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
